Protect Infant Formula from Contamination Act
Official title: A bill to improve the safety of infant formula through testing of infant formula for microorganisms, and for other purposes.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Held at the desk.
Protect Infant Formula from Contamination Act
This bill imposes certain new requirements on infant formula manufacturers and the Food and Drug Administration (FDA) following the discovery of contaminated, adulterated, or misbranded infant formula.
Specifically, the bill requires infant formula manufacturers to report to the FDA within one business day of learning that formula that was processed by the manufacturer but that is no longer within the manufacturer’s control may not provide required nutrients or may be otherwise adulterated or misbranded.
Further, if any testing of finished infant formula reveals the presence of specified microorganisms (e.g., salmonella), the manufacturer must notify the FDA within one business day. (Under current law, manufacturers are only required to report contamination to the FDA if the affected formula has left the manufacturer’s control.) The manufacturer must also promptly provide the test results to the FDA and consult with the FDA on proper isolation and disposal of the affected product. The FDA must respond to such a notification and begin discussing proper investigative and corrective action with the manufacturer within one business day.
Within 90 days of a report of adulterated, misbranded, or contaminated infant formula, the FDA must determine whether the manufacturer that reported the problem has performed, or is performing, appropriate investigative and corrective action.
Finally, the FDA is required to periodically report on the infant formula supply chain and efforts to improve the safety and supply of infant formula, and must consult with other federal agencies and infant formula stakeholders on these issues.
- Engrossed in Senate Formatted Text PDF Formatted XML
- Introduced in Senate Formatted Text PDF Formatted XML
- Reported to Senate Formatted Text PDF Formatted XML
- MASON CONSULTING, LLC
- CORBIN STRATEGIES LLC
- CORBIN STRATEGIES LLC
- CORBIN STRATEGIES LLC
- CORBIN STRATEGIES LLC
- MASON CONSULTING, LLC
Bodies those filers lobbied
- HOUSE OF REPRESENTATIVES
- SENATE
- Food & Drug Administration (FDA)
- Health & Human Services, Dept of (HHS)
- Natl Economic Council (NEC)
- White House Office
- Centers For Medicare and Medicaid Services (CMS)
- Labor, Dept of (DOL)
Cite this page
U.S. Congress. (2026). S. 272: Protect Infant Formula from Contamination Act. 119th Congress. Open America. https://openamerica.io/bill/119-S-272/
"S. 272: Protect Infant Formula from Contamination Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-272/.
S. 272, 119th Cong. (2026), https://openamerica.io/bill/119-S-272/.
[S. 272: Protect Infant Formula from Contamination Act](https://openamerica.io/bill/119-S-272/)